Press Releases about Astrazeneca Plc ADR
FASENRA approved in the US for eosinophilic granulomatosis with polyangiitis
September 18, 2024
From AstraZeneca
Via Business Wire
From AstraZeneca
Via Business Wire
From Cellectis Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|